UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy

Journal of allergy and clinical immunology, 2013-08, Vol.132 (2), p.353-360.e2

2013

Volltextzugriff (PDF)

Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients

PloS one, 2022-01, Vol.17 (1), p.e0261940-e0261940

2022

Volltextzugriff (PDF)

Impact of hospitalisation on health-related quality of life in patients with chronic heart failure

Health and quality of life outcomes, 2020-08, Vol.18 (1), p.262-262, Article 262

2020

Volltextzugriff (PDF)

Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations

The European journal of health economics, 2020-02, Vol.21 (1), p.153-164

2020

Volltextzugriff (PDF)

Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis

PloS one, 2018-10, Vol.13 (10), p.e0205013-e0205013

2018

Volltextzugriff (PDF)

Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes

PloS one, 2017-02, Vol.12 (2), p.e0171292-e0171292

2017

Volltextzugriff (PDF)

A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data

Value in health, 2017-09, Vol.20 (8), p.1041-1047

2017

Volltextzugriff (PDF)

Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis

Value in health, 2015-01, Vol.18 (1), p.100-109

2015

Volltextzugriff (PDF)

Developing and Applying a Stochastic Dynamic Population Model for Chronic Obstructive Pulmonary Disease

Value in health, 2011-12, Vol.14 (8), p.1039-1047

2011

Volltextzugriff (PDF)

Expected Value of Perfect Information: An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research

Value in health, 2008-12, Vol.11 (7), p.1070-1080

2008

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis

Value in health, 2018-02, Vol.21 (2), p.193-202

2018

Volltextzugriff (PDF)

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

OncoTargets and therapy, 2019-01, Vol.12, p.1413-1421

2019

Volltextzugriff (PDF)

Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics, 2019-02, Vol.37 (2), p.141-153

2019

Volltextzugriff (PDF)

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics, 2017-12, Vol.35 (12), p.1211-1221

2017

Volltextzugriff (PDF)

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data

Arthritis care & research (2010), 2016-03, Vol.68 (3), p.308-317

2016

Volltextzugriff (PDF)

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

PharmacoEconomics, 2018-02, Vol.36 (2), p.145-159

2018

Volltextzugriff (PDF)

Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework

Medical decision making, 2017-02, Vol.37 (2), p.162-172

2017

Volltextzugriff (PDF)

Cost-Effectiveness Acceptability Curves Revisited

PharmacoEconomics, 2013-02, Vol.31 (2), p.93-100

Al, Maiwenn J.

2013

Volltextzugriff (PDF)

The analysis of incomplete cost data due to dropout

Health economics, 2005-08, Vol.14 (8), p.763-776

2005

Volltextzugriff (PDF)

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

Applied health economics and health policy, 2019-12, Vol.17 (6), p.883-893

2019

Volltextzugriff (PDF)

Costs and Effects of Various Analgesic Treatments for Patients with Rheumatoid Arthritis and Osteoarthritis in The Netherlands

Value in health, 2008-07, Vol.11 (4), p.589-599

2008

Volltextzugriff (PDF)

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands

Critical care (London, England), 2010-01, Vol.14 (6), p.R195-R195

2010

Volltextzugriff (PDF)

Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene

PharmacoEconomics, 2016-01, Vol.34 (1), p.23-31

2016

Volltextzugriff (PDF)

Continuous versus Intermittent Data Collection of Health Care Utilization

Medical decision making, 2013-11, Vol.33 (8), p.998-1008

2013

Volltextzugriff (PDF)

The cost-utility of rotavirus vaccination with Rotarix ™ (RIX4414) in the Netherlands

Vaccine, 2008-02, Vol.26 (8), p.1118-1127

2008

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Pharmacoeconomics
(11)
Value In Health
(8)
Health Economics
(6)
Social Science & Medicine
(4)
Health Policy
(3)
Medical Decision Making
(3)
Plos One
(3)
Vaccine
(3)
Applied Health Economics And Health Policy
(2)
Cancer
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy

Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients

Impact of hospitalisation on health-related quality of life in patients with chronic heart failure

Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations

Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis

Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes

A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data

Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis

Developing and Applying a Stochastic Dynamic Population Model for Chronic Obstructive Pulmonary Disease

Expected Value of Perfect Information: An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research

Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework

Cost-Effectiveness Acceptability Curves Revisited

The analysis of incomplete cost data due to dropout

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

Costs and Effects of Various Analgesic Treatments for Patients with Rheumatoid Arthritis and Osteoarthritis in The Netherlands

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands

Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene

Continuous versus Intermittent Data Collection of Health Care Utilization

The cost-utility of rotavirus vaccination with Rotarix ™ (RIX4414) in the Netherlands

Suchergebnisse filtern